A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients
Clinical trial NCT05214976 · UNKNOWN
Trial details
- NCT number
- NCT05214976
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-12
- Primary completion
- 2023-01-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.